Related Experiment Video
Updated: Jun 27, 2026

Evaluation of Changes in Hydration and Body Cell Mass with Bioelectrical Impedance Analysis after Exercise Program for Rheumatoid Arthritis Patients
Published on: July 14, 2023
Rheumatoid arthritis: a female challenge
M Gerosa1, V De Angelis, P Riboldi
1San Luca Hospital, Allergy, Clinical Immunology & Rheumatology Unit, Via G Spagnoletto 3, 20149 Milan, Italy.
Rheumatoid arthritis (RA) affects women more frequently due to sex hormones and genetics. Pregnancy often induces remission in RA patients, but careful drug management is crucial during pregnancy and breastfeeding.
Area of Science:
- Immunology
- Endocrinology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) exhibits a higher prevalence in women, strongly linked to sex hormones and genetic factors on sexual chromosomes.
- Estrogens are implicated in regulating immune responses, potentially promoting autoimmunity and RA development in women.
- Pregnancy commonly leads to RA remission, associated with immune shifts (Th1 to Th2) and hormonal changes.
Purpose of the Study:
- To explore the influence of sex hormones and genetic factors on rheumatoid arthritis prevalence.
- To examine the impact of hormonal changes during pregnancy on RA disease activity and immune response.
- To provide guidance on safe antirheumatic and hormonal therapies for women with RA, considering pregnancy and menopause.
Main Methods:
- Review of existing literature on rheumatoid arthritis, sex hormones, genetics, and pregnancy.
- Analysis of immune response modulation (Th1/Th2) in RA patients during pregnancy.
- Evaluation of risks associated with hormonal therapies (contraception, hormone replacement) in RA patients.
Main Results:
- Sex hormones, particularly estrogens, and genetic factors contribute to the higher incidence of RA in women.
- Pregnancy-induced hormonal shifts facilitate RA remission by altering immune responses and reducing pro-inflammatory cytokines.
- Hormonal contraception is contraindicated in antiphospholipid antibody-positive RA patients due to thrombophilic risk.
- Hormone replacement therapy for osteoporosis in postmenopausal RA patients is not recommended due to increased cardiovascular risk.
Conclusions:
- Sex hormones and genetics play a significant role in the female predominance of rheumatoid arthritis.
- Pregnancy offers a unique window into RA pathogenesis and potential therapeutic modulation via hormonal changes.
- Careful consideration of hormonal therapies is essential for women with RA, balancing disease management with risks during reproductive years and post-menopause.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...

